Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia

Cell Host & Microbe(2021)10.1016/j.chom.2021.11.004Source: DataRank Database

Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia is a research paper published in Cell Host & Microbe (2021). On theSindex it has a DataRank of 0. It has been cited 78 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access78 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 4.56)OA: hybridTopics (88)Linked Datasets (6)DataCite Reuse (6)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (40)

Oliver F. Wirz ORCID,Katharina Röltgen ORCID,Emily Haraguchi,Anthony S. Buzzanco ORCID,Mamdouh Sibai

Live enrichment

PubMed:34861167 PMC:PMC8585611 OpenAlex:https://openalex.org/W3211888797

National Institute of Allergy and Infectious Diseases

Grant: 1U54CA260517

National Institute of Allergy and Infectious Diseases

Grant: HHSN272201700013C

National Institute of Allergy and Infectious Diseases

Grant: R01AI127877

National Institute of Allergy and Infectious Diseases

Grant: R01AI130398

NIAID NIH HHS

Grant: U19 AI167903

NCI NIH HHS

Grant: U54 CA260517

National Institutes of Health

Grant: 3U54CA260517-02S2

Mechanisms and Duration of Immunity to SARS-CoV-2

National Institutes of Health

Grant: 1R01AI130398-01

Effects of aging on primary and secondary vaccine responses in a 15-year longitudinal cohort

National Institutes of Health

Grant: 5R01AI127877-05

Storage and recall of human B cell memory of influenza over tissues and time

National Institutes of Health

FWCI

4.56

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.chom.2021.11.004

publisherhttps://doi.org/10.1016/j.chom.2021.11.004

publisherhttps://api.elsevier.com/content/article/PII:S1931312821005102?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1931312821005102?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34861167

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studiesvaccines and immunoinformatics approaches0301 basic medicine0303 health sciences03 medical and health sciencesAdultAgedAngiotensin-Converting Enzyme 2Antibodies, ViralBNT162 VaccineCOVID-19COVID-19 VaccinesChAdOx1 nCoV-19FemaleGene ExpressionHumansImmune SeraImmunogenicity, VaccineMaleMass VaccinationMiddle AgedMongoliaRetrospective StudiesSARS-CoV-2Vaccines, SyntheticSARS-CoV-2 variants

MeSH Terms

Immunogenicity, VaccineAngiotensin-Converting Enzyme 2COVID-19SARS-CoV-2COVID-19 VaccinesBNT162 VaccineChAdOx1 nCoV-19AdultAgedAntibodies, ViralFemaleHumansImmune SeraMaleMiddle AgedMongoliaRetrospective StudiesVaccines, SyntheticGene ExpressionMass Vaccination

Keywords

AntibodyVaccinationVirologyAntibody titerBiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)TiterCoronavirus disease 2019 (COVID-19)ImmunologyAntibody responseMedicineInfectious disease (medical specialty)DiseaseInternal medicineSerologyVaccineMongoliaViral VariantsCovid-19Sars-cov-2Pfizer/biontechSinopharmSputnik VAdultMaleVaccines, SyntheticCOVID-19 VaccinesBrief ReportImmune SeraGene ExpressionMiddle AgedAntibodies, ViralMass VaccinationImmunogenicity, VaccineChAdOx1 nCoV-19HumansFemaleAngiotensin-Converting Enzyme 2BNT162 VaccineAgedRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study

10.6084/m9.figshare.19633801.v1figshare

Additional file 1 of Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study

10.6084/m9.figshare.19633801figshare

Additional file 1 of SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia

10.6084/m9.figshare.21128140.v1figshare

Additional file 1 of SARS-CoV-2 infection, vaccination, and antibody response trajectories in adults: a cohort study in Catalonia

10.6084/m9.figshare.21128140figshare

Additional file 1 of RBD-specific antibody responses after two doses of BBIBP-CorV (Sinopharm, Beijing CNBG) vaccine

10.6084/m9.figshare.19029488figshare

Additional file 1 of RBD-specific antibody responses after two doses of BBIBP-CorV (Sinopharm, Beijing CNBG) vaccine

10.6084/m9.figshare.19029488.v1figshare

Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia

FAIR Checklist

Authors (40)

Funding (10 grants)

Impact

Open Access

Topics

Linked Datasets (6)

Annotations (Europe PMC)